|CRH Medical Corporation -- Canada Stock|| |
CAD 2.89 0.13 4.3%
Independent Chairman of the Board
Dr. Anthony F. Holler, M.D., is Independent Chairman of the Board of CRH Medical Corporationrationration, since December 21, 2005. Dr. Holler was appointed as a director of the Company on December 21, 2005. Dr. Holler is one of the founders of ID Biomedical Corporationrationration and held a number of executive positions with ID Biomedical including Chief Executive Officer and Director
Age: 62 Chairman Since 2005 Ph.D
Holler resigned from ID Biomedical upon the completion of ID Biomedical acquisition by GlaxoSmithKline. Prior to founding ID Biomedical, Dr. Holler served as an emergency physician at University Hospital at the University of British Columbia.
The company has return on total asset (ROA)
of 9.29 %
which means that it generated profit of $9.29 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 15.91 %
meaning that it generated $15.91 on every $100 dollars invested by stockholders.
The company has accumulated 42.26 M in total debt with debt to equity ratio (D/E) of 40.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CRH Medical Corporation has Current Ratio of 2.28 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
CRH Medical Corporationration offer solutions and services to physicians for the treatment of gastrointestinal diseases in the United States. CRH Medical Corporation (CRH) is traded on Toronto Stock Exchange in Canada. It is located in Vancouver, BC VC E and employs 13 people.